Literature DB >> 24719818

The gender effect of health-related quality of life in hemodialysis patients.

Eghlim Nemati1, Mohsen Motalebi1.   

Abstract

Entities:  

Keywords:  Gender Identity; Quality of Life; Renal Dialysis

Year:  2014        PMID: 24719818      PMCID: PMC3968987          DOI: 10.5812/numonthly.15934

Source DB:  PubMed          Journal:  Nephrourol Mon        ISSN: 2251-7006


× No keyword cloud information.
We read with great interest the recent published outstanding article in your esteemed journal by Rostami et al. (1) entitled “Health-related quality of life in hemodialysis patients: an Iranian multi-center study”. The message of this valuable and huge study focused on drawing the attention to the biographic, socio-economic, and biochemical factors, which can influence on health-related quality of life (HRQoL) of hemodialysis (HD) patients. The impact of gender on quality of life (QoL) has remained a challenge yet. Although Rostami and coworkers (1) showed that men had better QoL than women, other studies found that females had better (2) or equal (3) QoL when compared to males. There are some important subjects to note about gender effects on QoL which can help this matter: 1) higher prevalence and severity of psychological disorders such as major depressive disorder and anxiety disorder in females cause poorer HRQoL in women than men (4). 2) It seems females are more capable than males in providing and receiving emotional support. 3) Women benefit more from family support, but men receive more support from health care professionals (5). 4) Females with chronic kidney disease (CKD) have lower handgrip force, lower exercise tolerance, greater arm fat region, and less muscle area than males (6). 5) Higher prevalence of viral hepatitis in males on hemodialysis (7) can influence HRQoL in them. 6) It has been shown that other chronic disorders in HD patients can influence HRQoL (3). Anyway, it is important to note that there is a different for perception of QoL among various countries, areas, religious, ethnic groups, and races between both genders. It seems that a meta-analysis is needed to evaluate whether gender has any influence on QoL in HD patients. Although Rostami et al. (1) showed no difference between QoL among HD patients with and without diabetes , Anees et al. (8) found the QOL of HD patients with diabetes was poor in comparison to patients without diabetes. In addition, they showed HD patients with non-diabetic causes of CKD had a better QOL in physical health scope than HD patients with diabetes (8). Patients with diabetes have multiorgan damage such as vision and cardiac problem, renal failure, cerebrovascular and peripheral vascular disease, which can lead to amputation and diminished physical health. Moreover, high rate of sleep disorders were demonstrated in patients with diabetes (9). Hence, it seems that HD patients who suffer from diabetes have worse QoL than others. We agree that QoL in HD patients are poorer than normal population. It seems that besides preparing these patients for kidney transplantation and treatment of biochemical disorders, HD patients counseling can improve QoL. Abraham and coworkers (10) conducted a study to evaluate the effect of patients counseling on QoL and concluded patients counseling would improve QoL of HD patients in all domains; therefore, we can help these patients with our attention and counseling in addition to focus on treatment only.
  9 in total

1.  Gender and age differences in plasma carnitine, muscle strength, and exercise tolerance in haemodialysis patients.

Authors:  Dumitru Constantin-Teodosiu; Stephanie Young; Fiona Wellock; Anthony H Short; Richard P Burden; Anthony G Morgan; Paul L Greenhaff
Journal:  Nephrol Dial Transplant       Date:  2002-10       Impact factor: 5.992

2.  Women on hemodialysis have lower self-reported health-related quality of life scores but better survival than men.

Authors:  Yu-Sen Peng; Jenq-Wen Huang; Kuan-Yu Hung; Bing-Shi Lin; Chien-Yu Lin; Chwei-Shiun Yang; Tzen-Wen Chen; Ching-Chih Hsia; Da-Lung Chen; Wen-Ding Hsu; Chao-Fu Chang; Kwan-Dun Wu; Ru-Ping Lin; Tun-Jun Tsai; Wang-Yu Chen
Journal:  J Nephrol       Date:  2012-05-15       Impact factor: 3.902

3.  Dialysis-related factors affecting quality of life in patients on hemodialysis.

Authors:  Muhammad Anees; Farooq Hameed; Asim Mumtaz; Muhammad Ibrahim; Muhammad Nasir Saeed Khan
Journal:  Iran J Kidney Dis       Date:  2011-01       Impact factor: 0.892

4.  Health-related quality of life in a sample of Iranian patients on hemodialysis.

Authors:  Amir H Pakpour; Mohsen Saffari; Mir Saeed Yekaninejad; Davood Panahi; Adrian P Harrison; Stig Molsted
Journal:  Iran J Kidney Dis       Date:  2010-01       Impact factor: 0.892

5.  Predictors of quality of life in hemodialysis patients.

Authors:  Magda Bayoumi; Ali Al Harbi; Abdulkareem Al Suwaida; Mohammed Al Ghonaim; Jamal Al Wakeel; Adel Mishkiry
Journal:  Saudi J Kidney Dis Transpl       Date:  2013-03

6.  Estimation of quality of life in haemodialysis patients.

Authors:  S Abraham; A Ramachandran
Journal:  Indian J Pharm Sci       Date:  2012-11       Impact factor: 0.975

7.  Health-related quality of life in hemodialysis patients: an Iranian multi-center study.

Authors:  Zohreh Rostami; Behzad Einollahi; Mahboob Lessan-Pezeshki; Azam Soleimani Najaf Abadi; Susan Mohammadi Kebar; Heshmatollah Shahbazian; Atieh Makhlough; Khadijeh Makhdoomi; Mahmood Salesi; Mojgan Jalalzadeh
Journal:  Nephrourol Mon       Date:  2013-08-18

8.  Sleep quality, depression, and quality of life in elderly hemodialysis patients.

Authors:  Kultigin Turkmen; Fatih Mehmet Erdur; Ibrahim Guney; Abduzhappar Gaipov; Faruk Turgut; Lutfullah Altintepe; Mustafa Saglam; Halil Zeki Tonbul; Emaad M Abdel-Rahman
Journal:  Int J Nephrol Renovasc Dis       Date:  2012-10-08

9.  Health related quality of life in Iranian hemodialysis patients with viral hepatitis: changing epidemiology.

Authors:  Zohreh Rostami; Mahboob Lessan Pezeshki; Azam Soleimani Najaf Abadi; Behzad Einollahi
Journal:  Hepat Mon       Date:  2013-05-30       Impact factor: 0.660

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.